Adial Pharmaceuticals

ADILNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$11.029 M

$4.20 -4.54%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$7.98T

Loss-making

Shares outstanding

2,625,890

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#428BullFrog AIBFRG$11.1M
#429MetaViaMTVA$11.1M
#430Adial PharmaceuticalsADIL$11.0M
#431Moleculin BiotechMBRX$11.0M
#432CytoMed TherapeuticsGDTC$10.8M

What if Adial Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.2T

$11,513,799

Per share 2,741,381× higher

Bitcoin $1.74T

$663,262.76

Per share 157,920× higher

Nvidia $5.52T

$2,100,532

Per share 500,127× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Adial Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.